Atrial Fibrillation
Colchicine not protective against AF, myocardial injury after noncardiac chest surgery
Colchicine did not reduce risk for perioperative atrial fibrillation or myocardial injury vs. placebo after noncardiac chest surgery, but a speaker noted a slight trend toward protection from a composite of both outcomes.
Treating atrial high-rate episodes with edoxaban not effective, may be harmful
In patients with device-detected atrial high-rate episodes, treatment with edoxaban did not reduce ischemic events and increased risk for a composite of death and major bleeding compared with placebo, researchers reported.
Data show potential cardioprotective effects of birth control use
A large analysis of UK Biobank data indicated no increased CV risk from birth control and even suggested a potential cardioprotective effect from oral contraceptive use, researchers reported.
FDA approves several radiofrequency AF ablation catheters for use without fluoroscopy
Biosense Webster announced several of its products in its cardiac ablation portfolio have received FDA approval for use without fluoroscopy.
For shock-resistant AF, traditional measures ‘fail to capture’ ablation’s true benefit
Implantable device data show patients with shock-resistant atrial fibrillation fare better than conventional analyses demonstrate, experiencing a marked reduction in atrial tachyarrhythmia burden despite modest arrhythmia-free survival.
Study: Rivaroxaban shows similar safety, effectiveness to warfarin for patients with CKD
Rivaroxaban showed similar or lower risk for death, ischemic stroke and transient ischemic attack, and similar risk for bleeding compared with warfarin in adults with atrial fibrillation, according to recently published data.
ASPC congress to highlight all aspects of CVD prevention
The American Society for Preventive Cardiology Congress on CVD Prevention will be held Friday through Sunday and will emphasize inclusiveness by focusing on the “care of one and all” at risk for CVD.
Levels of omega-3 fatty acids in diet not linked to elevated risk for atrial fibrillation
Levels of omega-3 fatty acids, primarily from diet, were not related to risk for incident atrial fibrillation, according to a meta-analysis published in the Journal of the American College of Cardiology.
Oral anticoagulant prescription rates poor after newly diagnosed atrial fibrillation
Most patients with a new atrial fibrillation diagnosis and an elevated CHA2DS2-VASc score are not prescribed an oral anticoagulant with the first 6 months, contradictory to current guidelines for AF management, researchers reported.
Shortages affect availability of some drugs used in emergent cardiac care
Of the many drug shortages in the U.S. this year, several are used in cardiac emergencies, according to the American Society for Health-System Pharmacists.